Age‐related off‐label drug prescribing in pediatric patients in South Korea and consistency of labeling compared to the United States, Europe, and Japan

Documenti analoghi

• Pharmacokinetics and safety of erenumab in pediatric patients with migraine: A phase I, randomized, open‐label, multiple‐dose study
  di: Andrew D. Hershey, et al.
  Pubblicazione: (2024)
• Re‐discover the value of protein binding assessments in hepatic and renal impairment studies and its contributions in drug labels and dose decisions
  di: Jocelyn Courville, et al.
  Pubblicazione: (2024)
• Expert survey on real‐world data utilization and real‐world evidence generation for regulatory decision‐making in drug lifecycle in Korea
  di: Hankil Lee, et al.
  Pubblicazione: (2024)
• Drug–drug interactions between pemafibrate and statins on pharmacokinetics in healthy male volunteers: Open‐label, randomized, 6‐sequence, 3‐period crossover studies
  di: Tomohiro Kamimura, et al.
  Pubblicazione: (2024)
• Proposing a framework to quantify the potential impact of pharmacokinetic drug–drug interactions caused by a new drug candidate by using real world data about the target patient population
  di: Simon Dagenais, et al.
  Pubblicazione: (2024)